Skip to main content
OpenTrials

Clinical trial condition

Primary Peritoneal Carcinoma

Explore clinical trials studying Primary Peritoneal Carcinoma. Study availability and eligibility vary by location and protocol.

102 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Primary Peritoneal Carcinoma trial results

Completed

Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

NCT01381861

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California, San Diego La Jolla, California, United States
  • University of Southern California Los Angeles, California, United States
  • Palm Beach Cancer Institute West Palm Beach, Florida, United States
View Trial Details
Completed

A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT00939809

Conditions
Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +31 more
Locations
  • Georgia Regents University Medical Center Augusta, Georgia, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Nebraska Methodist Hospital Omaha, Nebraska, United States
  • Stony Brook University Medical Center Stony Brook, New York, United States
View all 16 locations
View Trial Details
Completed

Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors

NCT00301756

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +22 more
Locations
  • Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
  • Odette Cancer Centre- Sunnybrook Health Sciences Centre Toronto, Ontario, Canada
  • University Health Network Princess Margaret Cancer Center P2C Toronto, Ontario, Canada
  • University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
View Trial Details
Completed

Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

NCT01295489

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Sudarshan K Sharma MD Limted-Gynecologic Oncology Hinsdale, Illinois, United States
  • Memorial Medical Center Springfield, Illinois, United States
  • McFarland Clinic PC-William R Bliss Cancer Center Ames, Iowa, United States
  • Billings Clinic Cancer Center Billings, Montana, United States
View Trial Details
Completed

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT00499252

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Colorado Gynecologic Oncology Group Aurora, Colorado, United States
  • The Hospital of Central Connecticut New Britain, Connecticut, United States
  • Beebe Medical Center Lewes, Delaware, United States
  • Rush University Medical Center Chicago, Illinois, United States
View all 20 locations
View Trial Details
Completed

EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT01118052

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Gynecologic Oncology Group of Arizona Phoenix, Arizona, United States
  • University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View Trial Details

Related conditions